Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 38.

https://doi.org/10.1182/blood-2024-206598

Published: 2024

Journal Articles

Race and Ethnicity As a Category Poses Challenges in Global Registries: Experience from the Waustim Project of the Worldwide Network for Blood and Marrow Transplantation, WBMT

Nada Hamad, Hiroyuki Takamatsu, Luuk Gras, Linda Koster, Laurien Baaij, Anita D'Souza, Noel Estrada-Merly, Parameswaran N. Hari, Andrew J. Cowan, Wael Saber, Minako Iida, Shinichiro Okamoto, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Bor-Sheng Ko, KIM Wah HO, Christopher Liam, A Sim Goh, Sui Tan, Hira Mian, Ali Bazarbachi, Brig Qamar Un N Chaudhry, Rozan Alfar, Mohamed Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Arleigh McCurdy, Alaa Elhaddad, Feng Rong Wang, Meng Lv, Mickey Boon Chai Koh, John Snowden, Stefan Schonland, Donal P McLornan, Mette Heisenberg, Patrick J Hayden, Daniel Neumann, Rafael De La Camara, Raffaella Greco, Fabio Ciceri, Anna Sureda Balari, Anna Sureda Balari, Damiano Rondelli, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger W. Niederwieser, Laurent Garderet

Blood (2024) 144 (Supplement 1): 7848.

https://doi.org/10.1182/blood-2024-209898

Published: 2024

Journal Articles

Real-World Treatment Patterns and Outcomes of Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (BiTE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) at the Yale Cancer Center Network (YCCN)

Poy Theprungsirikul, Rong Wang, Man-Yee Merl, Shi-Yi Wang, Natalia Neparidze

Blood (2024) 144 (Supplement 1): 3775.

https://doi.org/10.1182/blood-2024-201603

Published: 2024

Journal Articles

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Blood (2024) 144 (Supplement 1): 4733.

https://doi.org/10.1182/blood-2024-200071

Published: 2024

Journal Articles

Use of Calcineurin Inhibitor (CNI) and Eltrombopag (EPAG) Among Patients with Acquired Aplastic Anemia (AA) in the United States: Results from a Large National Database

Jessica M. Stempel, Rong Wang, Alfred I Lee, Xiaomei Ma, Nikolai A. Podoltsev

Blood (2024) 144 (Supplement 1): 2319.

https://doi.org/10.1182/blood-2024-202185

Published: 2024

Journal Articles

Maintenance after Autologous Hematopoietic Cell Transplantation Improves Overall Survival and Progression Free Survival Regardless of Disease Stage at Transplant in Newly Diagnosed Myeloma Patients: A Global, Real-World Analysis from the Worldwide Network for Blood and Marrow Transplantation Global Study

Andrew J. Cowan, Luuk Gras, Hiroyuki Takamatsu, Linda Koster, Laurien Baaij, III, Nada Hamad, Anita D'Souza, Noel Estrada-Merly, Parameswaran N. Hari, Wael Saber, Minako Iida, Shinichiro Okamoto, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Bor-Sheng Ko, Christopher Liam, KIM Wah HO, A Sim Goh, S Keat Tan, Alaa M. Elhaddad, Ali Bazarbachi, Brig Qamar Un N Chaudhry, Rozan Alfar, Mohamed Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Hira Mian, Arleigh McCurdy, Feng-Rong Wang, Meng Lv, Daniel Neumann, Mickey Boon Chai Koh, John Snowden, Stefan Schonland, Donal P McLornan, Patrick John Hayden, Rafael De La Camara, Raffaella Greco, Fabio Ciceri, Mette D. Hazenberg, Anna Sureda Balari, Damiano Rondelli, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger W. Niederwieser, Laurent Garderet

Blood (2024) 144 (Supplement 1): 2379.

https://doi.org/10.1182/blood-2024-205709

Published: 2024

Journal Articles

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2024-204843

Published: 2024

Journal Articles

State‐Level Acute Myeloid Leukemia Incidence and Mortality Trends and Association with Obesity in the United States

Lixin Kang, Xiaomei Ma, Nikolai A. Podoltsev, Jessica M. Stempel, Rong Wang

Blood (2023) 142 (Supplement 1): 5184.

https://doi.org/10.1182/blood-2023-186428

Published: 2023

Journal Articles

Development and Validation of Deep Learning Model for Diagnosis and Subtypes Differentiation of Myeloproliferative Neoplasms Using Clinical Data and Digital Pathology

Rong Wang, Zhongxun Shi, Yuan Zhang, Minghui Duan, Min Xiao, Suning Chen, Jianyao Huang, Xiaomei Hu, Jinhong Mei, Wenyi Shen, Yongyue Wei, Jianyong Li

Blood (2023) 142 (Supplement 1): 123.

https://doi.org/10.1182/blood-2023-184459

Published: 2023

Journal Articles

Study on the Impact of G-CSF Mobilization on the Level of MDSCs in Donor Peripheral Blood and Its Correlation with Patient Prognosis

Man Chen, Rong Wang, Hui Wang

Blood (2023) 142 (Supplement 1): 7021.

https://doi.org/10.1182/blood-2023-180871

Published: 2023

Journal Articles

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Blood (2023) 142 (Supplement 1): 785.

https://doi.org/10.1182/blood-2023-179153

Published: 2023

Journal Articles

International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

Blood (2022) 140 (Supplement 1): 5225–5227.

https://doi.org/10.1182/blood-2022-165010

Published: 2022

Journal Articles

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

Rong Wang, Natalia Neparidze, Xiaomei Ma, Graham A Colditz, Su-Hsin Chang, Shi-Yi Wang

Blood (2022) 140 (Supplement 1): 5270–5271.

https://doi.org/10.1182/blood-2022-164741

Published: 2022

Journal Articles

Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

Blood (2022) 140 (Supplement 1): 4839–4842.

https://doi.org/10.1182/blood-2022-164619

Published: 2022

Journal Articles

Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

Mengyang Di, Jessica B Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory Michael Shallis, Rong Wang, Jessica M. Stempel, Xiaomei Ma, Scott F. Huntington

Blood (2022) 140 (Supplement 1): 10904–10906.

https://doi.org/10.1182/blood-2022-164959

Published: 2022

Journal Articles

Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib

Jessica M. Stempel, Rong Wang, Rory Michael Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev

Blood (2022) 140 (Supplement 1): 11004–11006.

https://doi.org/10.1182/blood-2022-165156

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Blood (2021) 138 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2021-150437

Published: 2021

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

Contemporary "Real World" Molecular Testing and Tyrosine Kinase Inhibitor Adherence Patterns Among Older Pts with Chronic Myeloid Leukemia in the United States

Rory M. Shallis, Rong Wang, Amer M. Zeidan, Scott F. Huntington, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai Podoltsev

Blood (2021) 138 (Supplement 1): 282.

https://doi.org/10.1182/blood-2021-151066

Published: 2021

NARROW

The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia

Race and Ethnicity As a Category Poses Challenges in Global Registries: Experience from the Waustim Project of the Worldwide Network for Blood and Marrow Transplantation, WBMT

Real-World Treatment Patterns and Outcomes of Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (BiTE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) at the Yale Cancer Center Network (YCCN)

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Use of Calcineurin Inhibitor (CNI) and Eltrombopag (EPAG) Among Patients with Acquired Aplastic Anemia (AA) in the United States: Results from a Large National Database

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

State‐Level Acute Myeloid Leukemia Incidence and Mortality Trends and Association with Obesity in the United States

Development and Validation of Deep Learning Model for Diagnosis and Subtypes Differentiation of Myeloproliferative Neoplasms Using Clinical Data and Digital Pathology

Study on the Impact of G-CSF Mobilization on the Level of MDSCs in Donor Peripheral Blood and Its Correlation with Patient Prognosis

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Contemporary "Real World" Molecular Testing and Tyrosine Kinase Inhibitor Adherence Patterns Among Older Pts with Chronic Myeloid Leukemia in the United States

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only